Leadership
Jay Walker leads ApiJect’s board of directors and leads the company’s operations as its Chief Executive Officer.
The inventor of ApiJect’s breakthrough BFS injection device is Marc Koska, one of the world’s most respected and successful social entrepreneurs.
Hanjin In is Chairman and CEO of Tae-Chang Industrial Co., Ltd. of South Korea (T-C), an ApiJect partner as well as a leading global manufacturer of needle products and blood bags. Since 2006 he has served as CEO and Chairman for both TCI and its Kovac-Med company, which manufactures specialty precision injection products. Over the past decade, as a Director of a growing number of TCI affiliates from Indonesia to France and Florida, he has also overseen all company operations worldwide.
Jon Ellenthal has devoted 30 years to starting, building, and leading early-stage companies that seek to change how an established industry does business.
Molly’s 15 years of experience in medical technology engineering and leadership includes serving as Vice President for Containment Systems & Portfolio Management at West Pharmaceutical Services. Earlier, she was VP of Quality & Regulatory and Chief Compliance Officer at Unilife Medical Corp.
Peter Stone has over 25 years’ experience in private equity, mergers and acquisitions and corporate finance, and as CFO of both private and publicly traded companies both domestically and internationally.
James (Jim) Garrett’s role at ApiJect includes expanding the company’s legal and governance infrastructure, and, as a member of the ApiJect Global Leadership Team, leading key initiatives and supporting growth drivers through proactive risk mitigation and opportunity assessment.
Amy Stewart is a Human Resources executive with 25 years of experience maximizing investment in human capital for organizations, including the past 15 years in the pharmaceutical industry.
Franco Negron Segarra is Senior Advisor to the Chairman of ApiJect, where he helps guide the company’s partnerships with leading pharmaceutical, biotech, and manufacturing service companies.
Mr. Guidotti comes to ApiJect with more than 30 years of pharma experience in global business, operational strategy and execution, supply chain management, manufacturing network design, and capital project planning and execution.
Nick Robinson brings extensive executive leadership experience to his leadership role at ApiJect.
Prior to joining ApiJect, Mr. Kowalczyk served as the Vice President of Sales, North America, for Syngene International’s Chemical Development and Manufacturing division, where he aligned operational expertise with prospecting efforts to target the right opportunities and maximize client satisfaction.
